Back to today’s briefing

Story perspectives

Revolutionary Gene Therapy Boosts CAR T-Cell Efficacy in Glioblastoma

7/5/2025

40 8

Summary

Story summary

A groundbreaking gene therapy developed by researchers at the San Raffaele-Telethon Institute in Milan is set to revolutionize CAR T-cell therapy for glioblastoma. By directing immune-boosting cytokines to the tumor's microenvironment, they significantly enhanced CAR T-cell effectiveness and prolonged survival in mice. This innovative strategy is now undergoing clinical trials to assess its safety and efficacy.

1 of 1

Story summary

A groundbreaking gene therapy developed by researchers at the San Raffaele-Telethon Institute in Milan is set to revolutionize CAR T-cell therapy for glioblastoma. By directing immune-boosting cytokines to the tumor's microenvironment, they significantly enhanced CAR T-cell effectiveness and prolonged survival in mice. This innovative strategy is now undergoing clinical trials to assess its safety and efficacy.